Image default
Water News

Pfizer/BioNTech’s Covid-19 vaccine: How the mRNA technology works


TheUK governmenthas become the first to give approval to the Pfizer/BioNTechvaccinewhich claims an efficacy of around 95 per cent. This means that the vaccine could be available as soon as next week.

The MHRA has formally given its approval to the Covid-19 vaccine.

The UK health secretary, Matt Hancock, tweeted that the NHS stands ready to start vaccinating early next week.

The vaccine maker, which used the mRNA technology for developing what is deemed as the fastest so far spanning just 10 months, had said that it will have manufactured enough doses to vaccinate close to 15 million to 20 million people by the end of the year.

The revolutionary mRNA technology

The messenger RNA technology has come as a boon to get much needed relief to the world in the form of an accelerated vaccine to protect against the deadly Covid-19 that has killed more than 1.2 million people worldwide.

Both the Pfizer/BioNTech and the Moderna vaccines use the revolutionary mRNA technology in their vaccines. The mRNA vaccine triggers response from body’s cells to make a spike protein, which is found on the surface ofcoronavirus. This then trains body’s immune system to recognise the virus and kill it by summoning body’s defences using antibodies and T-cells.

If a person actually encounters the coronavirus, the body recognises it and triggers antibodies to destroy the virus.

(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Related posts

Sustained shedding of COVID-19 active caseload continues; drops to 3.03 lakh after 161 days

TheEarthLab

J&J Covid vaccine: A shot at redemption for J&J?

TheEarthLab

Engineers use heat-free technology to make metallic replicas of a rose’s surface texture

TheEarthLab

Leave a Comment

Image default
Water News

Pfizer/BioNTech’s Covid-19 vaccine: How the mRNA technology works


TheUK governmenthas become the first to give approval to the Pfizer/BioNTechvaccinewhich claims an efficacy of around 95 per cent. This means that the vaccine could be available as soon as next week.

The MHRA has formally given its approval to the Covid-19 vaccine.

The UK health secretary, Matt Hancock, tweeted that the NHS stands ready to start vaccinating early next week.

The vaccine maker, which used the mRNA technology for developing what is deemed as the fastest so far spanning just 10 months, had said that it will have manufactured enough doses to vaccinate close to 15 million to 20 million people by the end of the year.

The revolutionary mRNA technology

The messenger RNA technology has come as a boon to get much needed relief to the world in the form of an accelerated vaccine to protect against the deadly Covid-19 that has killed more than 1.2 million people worldwide.

Both the Pfizer/BioNTech and the Moderna vaccines use the revolutionary mRNA technology in their vaccines. The mRNA vaccine triggers response from body’s cells to make a spike protein, which is found on the surface ofcoronavirus. This then trains body’s immune system to recognise the virus and kill it by summoning body’s defences using antibodies and T-cells.

If a person actually encounters the coronavirus, the body recognises it and triggers antibodies to destroy the virus.

(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Related posts

COVID-19: Distancing and masks — good but not enough

TheEarthLab

Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection

TheEarthLab

Global warming is changing our plant communities

TheEarthLab

Leave a Comment